Editorial: novel therapeutic approaches for the treatment of depression

Ayan Mohamud Yusuf; Dirk M. Hermann

doi:10.37349/en.2025.1006110

Exploration of Neuroscience ›› 2025, Vol. 4 ›› Issue (1) :1006110 DOI: 10.37349/en.2025.1006110

research-article

Editorial: novel therapeutic approaches for the treatment of depression

Author information +

History +

PDF (510KB)

Keywords

depression / treatment refractory depression / antidepressants / electroconvulsive treatment / transcranial magnetic stimulation / ketamine

Cite this article

Download citation ▾

Ayan Mohamud Yusuf, Dirk M. Hermann. Editorial: novel therapeutic approaches for the treatment of depression. Exploration of Neuroscience, 2025, 4 (1) : 1006110 DOI:10.37349/en.2025.1006110

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	GBD 2019 Mental Disorders Collaborators.Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Psychiatry.2022;9:137-50.

[2]	Cui L,Li S,Wang S,Wu X,Liu Y,Yu W,et al.Major depressive disorder: hypothesis, mechanism, prevention and treatment.Signal Transduct Target Ther.2024;9:30.

[3]	McIntyre RS,Alsuwaidan M,Baune BT,Berk M,Demyttenaere K,Goldberg JF,et al.Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions.World Psychiatry.2023;22:394-412.

[4]	Goischke HK.Multiple sclerosis with comorbidity depression and its association with vitamin D deficiency in a narrative review of the current literature.Explor Neurosci.2023;2:160-92.

[5]	Vollbracht C,Werner M.The role of inflammation and oxidative stress in the pathophysiology of depressions: time to consider vitamin C deficiency.Explor Neurosci.2024;3:287-94.

[6]	Jagtiani A.Novel treatments of depression: bridging the gap in current therapeutic approaches.Explor Neurosci.2024;3:272-86.

[7]	Norman TR.The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?Explor Neurosci.2025;4:1006105.

[8]	Ruiz-Marquez E.Neurophysiology of executive cognitive functions under depression.Explor Neurosci.2025;4:100696.

[9]	Ruiz-Marquez E.Protocol for measuring the benefits of exergames on executive functions under depression through a randomized multi-arm controlled experiment.Explor Neurosci.2024;3:564-83.

[10]	Posmontier B,Horowitz JA,Geller PA,Elgohail M,McDonough M,Alvares K,et al.Applying the PRECEDE-PROCEED model to develop MommaConnect: a digital healthcare platform for addressing postpartum depression and improving infant well-being.Explor Neurosci.2024;3:309-20.

[11]	Afshari B.Psychology of bipolar depression: revisiting past and present researches, prospects ahead, and moving toward future directions.Explor Neurosci.2023;2:331-49.